Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06215404

Fluid Management Strategies on Blood Loss in Liver Transplantation

During liver transplantation, due to the complexity of the operation and abnormal coagulation function, there may be a large amount of bleeding and corresponding blood transfusion. Excessive blood transfusion will increase pulmonary complications and affect the prognosis. Infusion management to reduce bleeding is a very important issue in liver transplant surgery. Restrictive infusion management can effectively reduce the amount of bleeding in liver transplantation, but it remains unclear whether it will cause sequelae in other major organs.

The investigators plan to study different infusion goals and strategies in liver transplant surgery using a randomized group model, using the PiCCO (Pulse Contour Cardiac Output) cardiopulmonary volume monitor, and setting the stroke volume variation (SVV) as the macroscopic circulation.The purpose of this study was to divide it into restrictive and liberal groups to explore the impact on liver transplantation bleeding volume and inflammatory response as well as postoperative lung and renal function, and to collect statistics on clinical care and postoperative sequelae (pulmonary liver, renal function impairment, etc.) in order to develop the most appropriate infusion management strategy in liver transplantation.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

National Taiwan University Hospital

Taipei, Taiwan

Location status: Recruiting

Location contact

Kuang-Cheng Chan

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • end stage liver disease
  • age between 18y/o to 75 y/o
  • expected to recieve to receive liver transplantation

Exclusion criteria

  • arrythmia

Treatment and study plan

Liberal group

Other

Fluid challage to keep stroke volume variation < 10%

restrictive group

Other

Fluid challage to keep stroke volume variation < 18%

Primary outcomes

  1. blood loss intraoperatively

    Time frame: during the operation

    blood loss intraoperatively in liver transplant

Secondary outcomes

  1. Lung injury biomarker

    Time frame: from biginning of the operation to postoprative day 1

    serum Clara Cell Protein (CC16)

  2. Kidney injury biomarker

    Time frame: from biginning of the operation to postoprative day 1

    serum Neutrophil Gelatinase Associated Lipocalins (NGALs)

  3. Influammatory reponses

    Time frame: from biginning of the operation to postoprative day 1

    IL-6

Study contacts

Contact information is provided by the study sponsor or research team.

Kuang-Cheng Chan, M.D.,PhD.

CONTACT

[email protected]

+886-2-23123456 ext. 262158

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Official study title

Effects of Different Fluid Management Strategies on Blood Loss, Inflammatory Response, and Major Organ Sequelae in Liver Transplantation

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jan 22, 2024
Registry last updated
Apr 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.